Th9细胞中PU.1-IL9正反馈环路促进类风湿关节炎发展
研究探讨Th9细胞中转录因子PU.1与白细胞介素-9(IL-9)在类风湿关节炎(RA)中的关系。RA患者IL-9表达上调且与临床标志物正相关;小鼠模型中靶向PU.1和IL-9可减轻炎症表型;体外实验显示IL-9促炎并形成PU.1-IL-9正反馈环路。作者认为靶向该轴是治疗RA的潜在方向。
要点
- RA患者中IL-9表达上调,且与临床标志物呈正相关。
- CAIA和CIA模型中靶向PU.1及IL-9可显著减轻炎症表型。
- PU.1与IL-9在RA中形成正反馈环路,靶向该轴为潜在治疗方向。
核心结论
- 结果支持PU.1-IL-9轴在Th9失调的RA中形成正反馈环路,靶向该信号轴是治疗RA的潜在方向。
研究设计与样本
- 采用ELISA、蛋白质印迹和免疫组化检测RA患者PU.1与IL-9表达水平。
- 使用PU.1 T细胞条件性敲除小鼠、IL-9敲除小鼠和IL-9R敲除小鼠分别建立胶原抗体诱导关节炎(CAIA)模型。
- 在胶原诱导关节炎(CIA)模型中使用PU.1抑制剂和IL-9阻断抗体。
- 体外研究使用siRNA和IL-9重组蛋白探讨IL-9的作用,并通过荧光素酶报告基因分析、蛋白质印迹和ChIP-qPCR进一步研究机制。
主要发现
- RA患者中IL-9表达上调,且与临床标志物呈正相关。
- CAIA和CIA模型中,靶向PU.1和IL-9的干预显著减轻炎症表型。
- 体外实验显示IL-9具有促炎作用,尤其表现为巨噬细胞和成纤维样滑膜细胞的过度活化。
- 机制上,PU.1直接结合IL-9启动子并激活其转录,Th9来源的IL-9通过IL-9R-JAK1/STAT3通路诱导PU.1,形成正反馈环路。
临床怎么用
- 作者认为靶向PU.1-IL-9信号轴是治疗RA的潜在方向。
局限性
- 原文在目的中表述IL-9与RA发病机制的确切关系需进一步阐明。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: T helper 9 (Th9) cells are recognised for their characteristic expression of the transcription factor PU.1 and production of interleukin-9 (IL-9), which has been implicated in various autoimmune diseases. However, its precise relationship with rheumatoid arthritis (RA) pathogenesis needs to be further clarified. METHODS: The expression levels of PU.1 and IL-9 in patients with RA were determined by ELISA, western blotting (WB) and immunohistochemical staining. PU.1-T cell-conditional knockout (KO) mice, IL-9 KO and IL-9R KO mice were used to establish collagen antibody-induced arthritis (CAIA), respectively. The inhibitor of PU.1 and IL-9 blocking antibody was used in collagen-induced arthritis (CIA). In an in vitro study, the effects of IL-9 were investigated using siRNAs and IL-9 recombinant proteins. Finally, the underlying mechanisms were further investigated by luciferase reporter analysis, WB and Chip-qPCR. RESULTS: The upregulation of IL-9 expression in patients with RA exhibited a positive correlation with clinical markers. Using CAIA and CIA model, we demonstrated that interventions targeting PU.1 and IL-9 substantially mitigated the inflammatory phenotype. Furthermore, in vitro assays provided the proinflammatory role of IL-9, particularly in the hyperactivation of macrophages and fibroblast-like synoviocytes. Mechanistically, we uncovered that PU.1 and IL-9 form a positive feedback loop in RA: (1) PU.1 directly binds to the IL-9 promoter, activating its transcription and (2) Th9-derived IL-9 induces PU.1 via the IL-9R-JAK1/STAT3 pathway. CONCLUSIONS: These results support that the PU.1-IL-9 axis forms a positive loop in Th9 dysregulation of RA. Targeting this signalling axis presents a potential target approach for treating RA.
引用
- Tu J, Chen W, Huang W, et al. Positive feedback loop PU.1-IL9 in Th9 promotes rheumatoid arthritis development. Ann Rheum Dis. 2024. PMID: 39164066. doi:10.1136/ard-2024-226067
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。